In recent trading session, BriaCell Therapeutics Corp (NASDAQ:BCTX) saw 0.59 million shares changing hands at last check today with its beta currently measuring 1.63. Company’s recent per share price level of $0.39 trading at -$0.04 or -10.23% at last check today assigns it a market valuation of $17.14M. That most recent trading price of BCTX’s stock is at a discount of -1261.54% from its 52-week high price of $5.31 and is indicating a discount of -5.13% from its 52-week low price of $0.41. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.33 million shares which gives us an average trading volume of 1.52 million if we extend that period to 3-months.

BriaCell Therapeutics Corp (NASDAQ:BCTX) trade information

Upright in the red during last session for losing -10.23%, in the last five days BCTX remained trading in the red while hitting it’s week-highest on Friday, 01/03/25 when the stock touched $0.39 price level, adding 40.0% to its value on the day. BriaCell Therapeutics Corp’s shares saw a change of -31.38% in year-to-date performance and have moved -33.16% in past 5-day. BriaCell Therapeutics Corp (NASDAQ:BCTX) showed a performance of -67.42% in past 30-days. Number of shares sold short was 0.69 million shares which calculate 0.77 days to cover the short interests.

BriaCell Therapeutics Corp (BCTX) estimates and forecasts

Statistics highlight that BriaCell Therapeutics Corp is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -57.54% of value to its shares in past 6 months, showing an annual growth rate of -248.28% while that of industry is 16.50. Apart from that, the company came lowering its revenue forecast for fiscal year 2025.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 47.85% during past 5 years.